Authors:
LOEFFLER M
BROSTEANU O
HASENCLEVER D
SEXTRO M
ASSOULINE D
BARTOLUCCI AA
CASSILETH PA
CROWTHER D
DIEHL V
FISHER RI
HOPPE RT
JACOBS P
PATER JL
PAVLOVSKY S
THOMPSON E
WIERNIK P
Citation: M. Loeffler et al., METAANALYSIS OF CHEMOTHERAPY VERSUS COMBINED-MODALITY TREATMENT TRIALS IN HODGKINS-DISEASE, Journal of clinical oncology, 16(3), 1998, pp. 818-829
Authors:
SIEBER M
RUEFFER U
TESCH H
LIEBERZ D
PAULUS U
BROSTEANU O
LOEFFLER M
PFREUNDSCHUH M
LATHAN B
DUHMKE E
GEORGII A
HILLER E
KOCH P
DOLKEN G
CERNY T
CARTONI C
MANDELLI F
DIEHL V
Citation: M. Sieber et al., RAPIDLY ALTERNATING COPP PLUS ABV PLUS IMEP (CAI) IS EQUALLY EFFECTIVE AS ALTERNATING COPP PLUS ABVD (CA) FOR HODGKINS-DISEASE - FINAL RESULTS OF 2 RANDOMIZED TRIALS FOR INTERMEDIATE (HD5 PROTOCOL) AND ADVANCED (HD6 PROTOCOL) STAGES, Blood, 90(10), 1997, pp. 2605-2605
Authors:
DUHMKE E
DIEHL V
LOEFFLER M
MUELLER RP
RUEHL U
WILLICH N
GEORGII A
ROTH S
MATTHAEI D
SEHLEN S
BROSTEANU O
HASENCLEVER D
WILKOWSKI R
BECKER K
Citation: E. Duhmke et al., RANDOMIZED TRIAL WITH EARLY-STAGE HODGKINS-DISEASE TESTING 30 GY VS 40 GY EXTENDED FIELD RADIOTHERAPY ALONE, International journal of radiation oncology, biology, physics, 36(2), 1996, pp. 305-310
Authors:
HINZ B
BROSTEANU O
JOHNEN C
KAISER H
ALT W
Citation: B. Hinz et al., NEW COMPUTER-ASSISTED METHODS FOR KERATINOCYTE SHAPE AND MOTILITY ANALYSIS - IN-VITRO TOOLS FOR CANCER-RESEARCH, Journal of investigative dermatology, 107(3), 1996, pp. 16-16
Authors:
LOEFFLER M
BROSTEANU O
HASENCLEVER D
SEXTRO M
COSSET J
DAHLBERG S
FISHER R
GRAY R
HENRYAMAR M
HOPPE R
SOMERS R
SPECHT L
Citation: M. Loeffler et al., COMBINED-MODALITY TREATMENT VS CHEMOTHERAPY ALONE IN HODGKINS-DISEASE(HD) - AN OVERVIEW ON RANDOMIZED TRIALS, Blood, 88(10), 1996, pp. 353-353
Citation: W. Alt et al., PATTERNS OF SPONTANEOUS MOTILITY IN VIDEOMICROGRAPHS OF HUMAN EPIDERMAL-KERATINOCYTES (HEK), Biochemistry and cell biology, 73(7-8), 1995, pp. 441-459
Authors:
MUNKER R
HASENCLEVER D
BROSTEANU O
HILLER E
DIEHL V
Citation: R. Munker et al., BONE-MARROW INVOLVEMENT IN HODGKINS-DISEASE - AN ANALYSIS OF 135 CONSECUTIVE CASES, Journal of clinical oncology, 13(2), 1995, pp. 403-409
Authors:
SCHMITZ N
HASENCLEVER D
BROSTEANU O
CARELLA A
COLOMBAT P
PROCTOR S
LEGROS M
BRADLEY S
PEARCE R
DIEHL V
GOLDSTONE AH
Citation: N. Schmitz et al., EARLY HIGH-DOSE THERAPY TO CONSOLIDATE PATIENTS WITH HIGH-RISK HODGKINS-DISEASE IN FIRST COMPLETE REMISSION - RESULTS OF AN EBMT GHSG MATCHED-PAIR ANALYSIS/, Blood, 86(10), 1995, pp. 1742-1742
Authors:
PFREUNDSCHUH MG
RUEFFER U
LATHAN B
SCHMITZ N
BROSTEANU O
HASENCLEVER D
HAAS R
KIRCHNER H
KOCH P
KUSE R
LOEFFLER M
DIEHL V
Citation: Mg. Pfreundschuh et al., DEXA-BEAM IN PATIENTS WITH HODGKINS-DISEASE REFRACTORY TO MULTIDRUG CHEMOTHERAPY REGIMENS - A TRIAL OF THE GERMAN HODGKINS-DISEASE STUDY-GROUP, Journal of clinical oncology, 12(3), 1994, pp. 580-586